Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
Teijin Pharma will launch Ipsen's Somatuline subcutaneous injection in 60mg, 90mg and 120mg doses, indicated to treat acromegaly and pituitary gigantism, in Japan. The medication is indicated for acromegaly and pituitary gigantism ...
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, ...
Tags: Octreotide Formulations, Aegis Therapeutics, polysorbate surfactants
European Medicines Agency's (EMA) Committee for Orphan Medicinal Products has announced positive opinion for granting orphan disease designation to Aspireo Pharmaceuticals' Somatoprim for the treatment of acromegaly. Somatoprim, the ...